OESIL Score for Syncope
The OESIL Score predicts short‑term mortality risk in syncope patients using four clinical variables.
Indications d'utilisation
Used in adults with unexplained syncope after initial ED evaluation to estimate short‑term (30‑day) mortality risk, guiding decisions on admission vs. discharge. Derived/validated in ED cohorts; higher scores correlate with increased mortality (sensitivity 95%, specificity 31%) 1 [Level II evidence]; meta‑analysis confirms modest prognostic accuracy compared with other tools 2 [Level II evidence].
Informations et précautions
Identifies short‑term mortality risk using four items (age > 65, abnormal ECG, history of heart disease, no prodrome). Mortality rises with accumulating points, but accuracy is limited: pooled sensitivity ~95% and specificity ~31% in validation studies (meta‑analysis, 5 studies) 1 [Level II evidence]. International comparison shows inferior discrimination vs CSRS (AUC 0.74 vs 0.85) 2 [Level II evidence]. Use cautiously—overestimates risk and performs worse than structured clinical judgment.